Nathan A. Pennell MD, PhD, FASCO· @n8pennell · X·· 3 天前评分70
正文 · 机器翻译
有没有想过，在 #ESMO26 与您会面的间隙，那支制药团队在做什么？我们在隔壁房间喝着咖啡、吃着零食，谈论您（全是好话），并整合我们所了解的信息，让您的见解帮助我们更快地将创新药物带给患者！#NateInTheHall
102 浏览 · 3 赞 · 0 转发 · 1 回复
会议摘要
Emotional distress (ED) upfront neoadjuvant ipilimumab + nivolumab (IPI+NIVO) is associated with lower pathological response and toxicity
https://esmocongress.esmo.orgImpact of BRAF V600K mutation in patients with resectable stage III melanoma: A subgroup analysis of the NADINA trial
https://esmocongress.esmo.org帖内回复
- Mario Balsa@MarioBalsaMD
@n8pennell So THAT is what happens between meetings!!! 👀 If listening to oncologists over coffee helped give us NADINA, I fully support the process!
来源：Nathan A. Pennell MD, PhD, FASCO · x.com